Turnstone Biologics Ownership | Who Owns Turnstone Biologics?


OverviewFinancialsChart

Turnstone Biologics Ownership Summary


Turnstone Biologics is owned by 36.45% institutional investors, 7.70% insiders, and 55.85% retail investors. Orbimed advisors is the largest institutional shareholder, holding 13.39% of TSBX shares.

TSBX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTurnstone Biologics36.45%7.70%55.85%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors3.10M13.39%$1.11M
Bml capital management1.10M4.77%$396.12K
Takeda pharmaceutical895.82K3.87%$321.60K
Point72 asset management816.92K3.53%$293.27K
72 investment549.98K2.38%$225.49K
Deltec asset management106.06K0.46%$38.07K
Hrt financial lp55.86K0.24%$20.00K
Gts securities45.16K0.20%$16.21K
Millennium management38.86K0.17%$15.93K
Xtx topco37.79K0.16%$13.56K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Takeda pharmaceutical895.82K1.64%$321.60K
72 investment549.98K0.63%$225.49K
Bml capital management1.10M0.30%$396.12K
Orbimed advisors3.10M0.03%$1.11M
Deltec asset management106.06K0.01%$38.07K
Gts securities45.16K0.00%$16.21K
Xtx topco37.79K0.00%$13.56K
Point72 asset management816.92K0.00%$293.27K
Hrt financial lp55.86K0.00%$20.00K
Pfm health sciences, lp---

Top Buyers

HolderShares% AssetsChange
Deltec asset management106.06K0.01%106.06K
Gts securities45.16K0.00%45.16K
Hrt financial lp55.86K0.00%43.78K
Xtx topco37.79K0.00%2.04K
Orbimed advisors3.10M0.03%-

Top Sellers

HolderShares% AssetsChange
Pfm health sciences, lp---932.35K
Sectoral asset management---517.65K
Fil---192.66K
Point72 asset management816.92K0.00%-62.01K
Citigroup---61.41K

New Positions

HolderShares% AssetsChangeValue
Deltec asset management106.06K0.01%106.06K$38.07K
Gts securities45.16K0.00%45.16K$16.21K

Sold Out

HolderChange
Virtu financial-14.81K
Nordwand advisors-20.00K
Goldman sachs group-20.52K
Citigroup-61.41K
Fil-192.66K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202523-8,434,667-18.84%361.81%716.67%8-20.00%
Mar 31, 20254-85.71%4,620,451-58.36%190.86%--100.00%1-83.33%
Dec 31, 20242816.67%11,096,493-3.03%481.95%1385.71%6-40.00%
Sep 30, 202424-45.45%11,443,046-9.91%491.63%7-73.08%10-16.67%
Jun 30, 20244410.00%12,701,707-4.85%551.64%268.33%1250.00%

Recent Insider Transactions


DateNameRoleActivityValue
Jul 25, 2023Versant Ventures V, LLC-Buy$2.37M
Jul 25, 2023Versant Ventures V, LLC-Buy$180.34K
Jul 25, 2023Versant Ventures V, LLC-Buy$78.90K
Jul 25, 2023Versant Ventures V, LLC-Buy$71.27K
Jul 20, 2023ORBIMED ADVISORS LLC Buy$5.00M

Insider Transactions Trends


DateBuySell
2025 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q35-

TSBX Ownership FAQ


Who Owns Turnstone Biologics?

Turnstone Biologics shareholders are primarily institutional investors at 36.45%, followed by 7.70% insiders and 55.85% retail investors. The average institutional ownership in Turnstone Biologics's industry, Biotech Stocks , is 306.59%, which Turnstone Biologics falls below.

Who owns the most shares of Turnstone Biologics?

Turnstone Biologics’s largest shareholders are Orbimed advisors (3.1M shares, 13.39%), Bml capital management (1.1M shares, 4.77%), and Takeda pharmaceutical (895.82K shares, 3.87%). Together, they hold 22.03% of Turnstone Biologics’s total shares outstanding.

Does Blackrock own Turnstone Biologics?

BlackRock is not among the top 10 institutional shareholders of Turnstone Biologics.

Who is Turnstone Biologics’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is Turnstone Biologics’s biggest shareholder by percentage of total assets invested, with 1.64% of its assets in 895.82K Turnstone Biologics shares, valued at 321.6K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools